middle.news
OncoSil Medical Advances FDA Approval Bid for Rare Bile Duct Cancer Device
8:27am on Friday 3rd of July, 2026 AEST
•
Healthcare
Read Story
OncoSil Medical Advances FDA Approval Bid for Rare Bile Duct Cancer Device
8:27am on Friday 3rd of July, 2026 AEST
Key Points
FDA review underway for OncoSil™ device HDE application
Potential first FDA-approved Class III device for distal cholangiocarcinoma
Entry into US market would mark OncoSil’s first commercial approval there
FDA decision expected within approximately 45 days
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE